astatine has been researched along with Leukemia--Myeloid--Acute* in 3 studies
3 other study(ies) available for astatine and Leukemia--Myeloid--Acute
| Article | Year |
|---|---|
Development of [
Radioimmunotherapy (RIT) has long been pursued to improve outcomes in acute leukemia and higher-risk myelodysplastic syndrome (MDS). Of increasing interest are alpha-particle-emitting radionuclides such as astatine-211 ( Topics: Acute Disease; Animals; Antibodies, Monoclonal; Astatine; Humans; Interleukin-3 Receptor alpha Subunit; Leukemia, Myeloid, Acute; Mice; Radioimmunotherapy | 2022 |
Tumour localisation of 211At-labelled monoclonal antibody to a sub-cutaneous human heterograft in the nude mouse II.
Topics: Animals; Antibodies, Monoclonal; Astatine; Female; Humans; Leukemia, Myeloid, Acute; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Transplantation, Heterologous | 1983 |
The specific inhibition of cellular clonogenic proliferation using 211At labelled lectins and antibodies--I.
A monoclonal antibody with a broad anti-human leucocyte specificity, designated BK 19.45 and the plant lectin Concanavalin A have been labelled with the alpha-emitting cyclotron produced radiohalogen astatine-211. Both human and murine tumour cell lines and human leukemic bone marrow samples have been specifically labelled with these radioactive proteins. In all cases the amount of 211At bound to the cells is directly correlated with a decrease in cellular reproductive potential as shown by the ability of the cells to proliferate in a clonogenic assay. For the labelled monoclonal antibody experiments, the radiation dose needed to yield 37% cell survival, the D37 dose, may be achieved with an average of 12 211At atoms/cell. Topics: Animals; Antibodies, Monoclonal; Astatine; Cell Line; Cell Survival; Colony-Forming Units Assay; Concanavalin A; Dose-Response Relationship, Radiation; Humans; Lectins; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Mice; Plasmacytoma | 1982 |